Evidence-Based Medicine Guidelines
Flumazenil for hepatic encephalopathy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Flumazenil for Hepatic Encephalopathy." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454321/all/Flumazenil_for_hepatic_encephalopathy.
Flumazenil for hepatic encephalopathy. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/454321/all/Flumazenil_for_hepatic_encephalopathy. Accessed March 21, 2025.
Flumazenil for hepatic encephalopathy. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/454321/all/Flumazenil_for_hepatic_encephalopathy
Flumazenil for Hepatic Encephalopathy [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454321/all/Flumazenil_for_hepatic_encephalopathy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Flumazenil for hepatic encephalopathy
ID - 454321
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454321/all/Flumazenil_for_hepatic_encephalopathy
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
